242 related articles for article (PubMed ID: 23117439)
21. P2 Receptors Influence hMSCs Differentiation towards Endothelial Cell and Smooth Muscle Cell Lineages.
Zhang Y; Babczyk P; Pansky A; Kassack MU; Tobiasch E
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867347
[TBL] [Abstract][Full Text] [Related]
22. P2X2, P2X4 and P2Y1 receptors elevate intracellular Ca2+ in mouse embryonic stem cell-derived GABAergic neurons.
Khaira SK; Pouton CW; Haynes JM
Br J Pharmacol; 2009 Dec; 158(8):1922-31. PubMed ID: 20050186
[TBL] [Abstract][Full Text] [Related]
23. Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.
Wu XM; Zhang N; Li JS; Yang ZH; Huang XL; Yang XF
Purinergic Signal; 2023 Mar; 19(1):265-272. PubMed ID: 34981330
[TBL] [Abstract][Full Text] [Related]
24. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
25. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
Bowler JW; Bailey RJ; North RA; Surprenant A
Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
[TBL] [Abstract][Full Text] [Related]
27. P2X7-related modulation of pathological nociception in rats.
McGaraughty S; Chu KL; Namovic MT; Donnelly-Roberts DL; Harris RR; Zhang XF; Shieh CC; Wismer CT; Zhu CZ; Gauvin DM; Fabiyi AC; Honore P; Gregg RJ; Kort ME; Nelson DW; Carroll WA; Marsh K; Faltynek CR; Jarvis MF
Neuroscience; 2007 Jun; 146(4):1817-28. PubMed ID: 17478048
[TBL] [Abstract][Full Text] [Related]
28. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
Haanes KA; Labastida-Ramírez A; Blixt FW; Rubio-Beltrán E; Dirven CM; Danser AH; Edvinsson L; MaassenVanDenBrink A
Cephalalgia; 2019 Oct; 39(11):1421-1434. PubMed ID: 31104506
[TBL] [Abstract][Full Text] [Related]
29. Role of P2Y receptor subtypes in platelet-derived microparticle generation.
Kahner BN; Dorsam RT; Kunapuli SP
Front Biosci; 2008 Jan; 13():433-9. PubMed ID: 17981558
[TBL] [Abstract][Full Text] [Related]
30. P2Y
Communi D; Horckmans M; Boeynaems JM
Biochem Pharmacol; 2021 May; 187():114347. PubMed ID: 33232731
[TBL] [Abstract][Full Text] [Related]
31. Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats.
Teixeira JM; Oliveira MC; Nociti FH; Clemente-Napimoga JT; Pelegrini-da-Silva A; Parada CA; Tambeli CH
Eur J Pharmacol; 2010 Oct; 645(1-3):79-85. PubMed ID: 20558155
[TBL] [Abstract][Full Text] [Related]
32. Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: Evidence from purine biosensors and P2 receptor agonists and antagonists.
Lopatář J; Dale N; Frenguelli BG
Neuropharmacology; 2011; 61(1-2):25-34. PubMed ID: 21338615
[TBL] [Abstract][Full Text] [Related]
33. Potent P2Y6 receptor mediated contractions in human cerebral arteries.
Malmsjö M; Hou M; Pendergast W; Erlinge D; Edvinsson L
BMC Pharmacol; 2003 May; 3():4. PubMed ID: 12737633
[TBL] [Abstract][Full Text] [Related]
34. Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders.
Huang L; Otrokocsi L; Sperlágh B
Brain Res Bull; 2019 Sep; 151():55-64. PubMed ID: 30721770
[TBL] [Abstract][Full Text] [Related]
35. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes.
Inoue K; Hosoi J; Denda M
J Invest Dermatol; 2007 Feb; 127(2):362-71. PubMed ID: 16946718
[TBL] [Abstract][Full Text] [Related]
36. Effects of anions on ATP-induced [Ca2+], increase in NG108-15 cells.
Watano T; Matsuoka I; Ogawa K; Kimura J
Jpn J Pharmacol; 2002 Jul; 89(3):302-8. PubMed ID: 12184737
[TBL] [Abstract][Full Text] [Related]
37. Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages.
Barberà-Cremades M; Baroja-Mazo A; Pelegrín P
J Leukoc Biol; 2016 Feb; 99(2):289-99. PubMed ID: 26382298
[TBL] [Abstract][Full Text] [Related]
38. Molecular pharmacology of P2Y-receptors.
von Kügelgen I; Wetter A
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
[TBL] [Abstract][Full Text] [Related]
39. P2 receptors activated by uracil nucleotides--an update.
Brunschweiger A; Müller CE
Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
[TBL] [Abstract][Full Text] [Related]
40. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells.
Wang L; Karlsson L; Moses S; Hultgårdh-Nilsson A; Andersson M; Borna C; Gudbjartsson T; Jern S; Erlinge D
J Cardiovasc Pharmacol; 2002 Dec; 40(6):841-53. PubMed ID: 12451317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
